References
- Axon ATR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 6: 131–7
- Borody TJ, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431–5
- George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9
- Oderda G, Deri'Olio D, Poli E, et al. Cure of peptic ulcer in children after eradication of Helicobacter pylori. Rev Esp Enf Digest 1990; 78: 105–6, Suppl 1
- Patchett S, Beattie S, Leen E, et al. The role of HP eradication on the natural history of duodenal ulcer disease. Rev Esp Enf Digest 1990; 78: 121–2, Suppl 1
- Rauws EA, Tytgat GNJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990; 1: 1233–5
- Alestig K. Studies on the intestinal excretion of doxycycline. Scand J Infect Dis 1974; 6: 265–71
- World Medical Assembly. The declaration of Helsinki. World Med J 1982; 29: 86–8
- Hazel SL, Borody TJ, Gal A, Lee A. Campylobacter pyloridis gastritis. I. Detection of urease as a marker of bacterial colonisation and gastritis. Am J Gastroenterol 1987; 82: 292–6
- Marshall BJ, Warren JR. Unidentified curved bacilli in the stomachs of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–5
- Whitehead R, Truelove SC, Gear MWC. The histological diagnosis of gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972; 25: 1–11
- Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
- Mathai E, O'Riordan T, Tobin A, et al. Drug resistance in Campylobacter pylori. Klin Wochenschr 1989; 67: 46, Suppl XVIII
- Hollingsworth JA, Goldie J, Silletti Y, Richardson HH, Hunt RH. Gastric secretion of antibiotics used for Campylobacter pyloridis. Gut 1987; 28: A1409
- Morris A, Rose T, Nicholson G. Treatment failure of doxycycline in Campylobacter pylori infection. J Gastroenterol Hepatol 1987; 2: 597–8
- Glupczynski Y, Bourdeaux L, Verhas M, et al. Short term double or triple oral drug treatment of Helicobacter pylori (HP) in Central Africa. Gastroenterology 1990; 98: A48
- Ching CK, Leake HA. Therapy in Helicobacter pylori infection [letter]. Lancet 1990; 336: 1380
- Hegedus E(Dick), Lee A. Use of a mouse model to examine anti-Helicobacter pylori agents. Gastroenterology 1991; 100: A81
- Chin TF, Lach JL. Drug diffusion and bioavailability; tetracycline metallic chelation. Am J Pharmacol 1975; 32: 625–9